Skip to main content
AEHR Test Systems (AEHR)
Electronics Information Technology
Stock AI

AEHR Test Systems 2024 Annual Report: A Year of Growth and Innovation

Last updated: July 30, 2024
Taurigo

Aehr Test Systems, a frontrunner in the semiconductor testing solutions market, has released its annual report for the fiscal year 2024, showcasing a year marked by significant revenue growth and strategic product innovations. As the demand for semiconductors continues to surge across various sectors, AEHR is well-positioned to capitalize on these trends.

1. Overview of Financial Performance

In fiscal year 2024, AEHR Test Systems reported a revenue increase of $1.3 million, bringing the total revenue to $66.21 million, up from $64.96 million in 2023. This growth is primarily attributed to a significant rise in sales of contactors, which saw an impressive growth of 71.72% year-over-year.

Revenue Breakdown

The company's revenue is derived from several key geographic regions and product segments. The following pie charts illustrate the distribution of revenue by geography and product/service type for the year 2024.

Revenue by Geography in 2024
Revenue by Products or Services in 2024

Product Line Highlights

AEHR's innovative product lineup has been a cornerstone of its growth strategy. The introduction of the FOX-P family of test and burn-in systems, as well as the FOX WaferPak and DiePak systems, has allowed AEHR to meet the evolving needs of the semiconductor industry.

Despite a decline in revenue from systems, which dropped by 37.78%, the overall performance was buoyed by the robust growth in contactors and steady service revenue.

2. Operating Results and Margins

Gross margin for AEHR decreased slightly from 50.4% in 2023 to 49.1% in 2024. This decline was primarily due to increased inventory reserves and higher costs associated with design changes. The company remains focused on improving manufacturing efficiencies and reducing direct material costs to enhance profitability.

Expense Management

Research and development (R&D) expenses increased by $1.6 million to $8.71 million, reflecting the company's commitment to innovation through higher employment-related costs and engineering services. Selling, general, and administrative expenses also rose by $1.5 million, reaching $13.74 million, driven by increased legal and audit service fees.

3. Geographic Revenue Insights

The geographic revenue distribution reflects a strategic shift towards international markets. Revenues from Asia grew by 4.44% to $58.07 million, while Europe saw an astonishing increase from just $63,000 in 2023 to $4.61 million in 2024, marking a remarkable growth of 7,210%. However, revenue from the United States declined by 61.98%, highlighting the competitive pressures and challenges faced in the domestic market.

4. Balance Sheet Strength

AEHR's balance sheet shows robust growth, with total assets rising to $127.9 million, up from $98.14 million in 2023. The company reported cash and cash equivalents of $49.15 million, a significant increase from $30.05 million the previous year, providing a strong liquidity position to support ongoing operations and future investments.

Balance Sheet of AEHR Test Systems
Aug 2023 Jul 2024
Total Assets
98.14M127.9M
Total Current Assets
89.03M97.84M
Cash and Equivalents
30.05M49.15M
Short-term Investments
17.85M0
Net Inventories
23.90M37.47M
Accounts Receivable
16.59M0
Prepaid Expenses
621K1.42M
Other Current Assets
09.79M
Total Non-current Assets
9.11M30.06M
Non-current Deferred Tax Assets
020.77M
Net PP&E
2.75M3.25M
Lease Assets
6.12M5.73M
Other Non-current Assets
231K304K
Total Liabilities and Equity
98.14M127.9M
Total Liabilities
22.54M16.31M
Total Current Liabilities
16.30M10.50M
Accounts Payable and Accrued Liabilities
13.34M8.69M
Current Debt
137K465K
Current Deferred Revenue
01.34M
Other Current Liabilities
2.82M0
Total Non-current Liabilities
6.23M5.81M
Non-current Deferred Revenue
31K41K
Other Non-current Liabilities
6.20M5.77M
Total Equity and Non-controlling Interests
75.6M111.5M
Total Equity
75.6M111.5M

5. Cash Flow Analysis

The cash flow statement reveals a net change in cash of $19.10 million for 2024, a substantial turnaround from a negative cash flow of $1.36 million in 2023. This improvement is primarily due to increased operating cash flow, indicating that AEHR is generating sufficient funds to support its growth initiatives.

Cash Flow Statement of AEHR Test Systems
Aug 2023 Jul 2024
Net Change in Cash
-1.36M19.10M
Effect of Exchange Rate Changes
-37K-41K
Net Cash from Operating Activities
10.01M1.75M
Operating Profit
14.55M33.15M
Adjustment to Operating Profit
-4.54M-31.4M
Net Cash from Investing Activities
-18.65M17.25M
Investments
17.29M-18M
Productive Assets
1.36M749K
Net Cash from Financing Activities
7.32M139K
Equity Issuance/Repurchase
6.82M1.73M
Other Financing Activities
502K-1.59M

6. Legal Proceedings and Market Outlook

In a positive note, AEHR confirmed that there are no ongoing or pending legal proceedings against the company, which bodes well for its reputation and operational stability.

The outlook for AEHR remains positive as it continues to navigate the semiconductor industry's complexities. With its innovative solutions and commitment to quality, AEHR is poised to capture further market share in the growing sectors of electric vehicles, renewable energy, and telecommunications.

7. Conclusion

AEHR Test Systems has demonstrated resilience and growth in an increasingly competitive environment. With a solid financial foundation, strategic investments in R&D, and a commitment to innovation, AEHR is well-equipped to meet the demands of the semiconductor market in the coming years. The focus on international expansion and product development positions the company for continued success in 2025 and beyond.

Income Statement of AEHR Test Systems
Aug 2023 Jul 2024
Net Income
14.55M33.15M
Profit
14.55M33.15M
Net Income Continuing
14.55M33.15M
Income Tax Expense
60K-20.69M
Pretax Income
14.61M12.45M
Non-operating Income
1.24M2.38M
Operating Income
13.37M10.07M
Revenue
64.96M66.21M
Costs and Expenses
51.58M56.14M
Cost of Revenue
32.21M33.67M
Operating Expenses
19.37M22.46M
Research & Development
7.13M8.71M
Selling, General & Administrative
12.23M13.74M
You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.